CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 48 enrolled
Drug / intervention
Previct Drugsdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05731999
NCT05731999N/ACompleted
CompareCT.gov

A First-in-human Explorative Pilot Study in Healthy Volunteers Measuring Eye Parameters With a New Mobile Phone Application for Future Monitoring of Patients in Treatment of Substance Use Disorder

Kontigo Care AB·interventional·Posted Feb 16, 2023·Updated Apr 2, 2025

In Brief

A clinical study evaluating Previct Drugs for Drug Abuse. Completed, enrolled 48 participants across 1 site.

Detailed Summary

This is a pre-market, explorative, early feasibility, pilot, controlled clinical investigation designed to collect initial clinical data on the medical device Previct Drugs.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDrug Abuse
CountriesNetherlands
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedFeb 16, 2023
Enrollment StartFeb 15, 2023
Primary CompletionJul 19, 2023
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 3.4 years ago

Interventions

Previct Drugsdevice

Previct Drugs is a new non CE-marked eHealth system intended to be used for future monitoring and treatment of patients with substance use disorder (SUD). Previct Drugs consists of an application (app) to be installed on a smartphone, a web-based careportal to be accessed from a computer by the healthcare professional for administration and access of registered data, and a database for storage, handling, and analysis of reported data. Previct Drugs is intended to be used by healthcare professionals and patients within treatment of SUD.